Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sue Reynolds

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Open Forum Infectious Diseases|April 18, 2015
Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnelMaryrose R Laguio-Vila, Mark G Thompson, Sue Reynolds, et al.
Frontiers in Public Health|July 8, 2021
Logically Inferred Tuberculosis Transmission (LITT): A Data Integration Algorithm to Rank Potential Source CasesKathryn Winglee, Clinton J McDaniel, Lauren Linde, et al.
Pediatrics|September 2, 2021
Influenza Antiviral Treatment and Length of StayAngela P Campbell, Jerome I Tokars, Sue Reynolds, et al.
Vaccine|September 12, 2021
Influenza vaccine effectiveness within prospective cohorts of healthcare personnel in Israel and Peru 2016-2019Mark G Thompson, Giselle Soto, Alon Peretz, et al.
The Journal of Infectious Diseases|November 23, 2022
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022Malini B DeSilva, Patrick K Mitchell, Nicola P Klein, et al.
Vaccine|July 21, 2023
Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021Peter J Embi, Matthew E Levy, Palak Patel, et al.
The New England Journal of Medicine|September 8, 2021
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care SettingsMark G Thompson, Edward Stenehjem, Shaun Grannis, et al.
MMWR. Morbidity and Mortality Weekly Report|January 27, 2022
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022Mark G Thompson, Karthik Natarajan, Stephanie A Irving, et al.
MMWR. Morbidity and Mortality Weekly Report|March 3, 2022
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022Nicola P Klein, Melissa S Stockwell, Maria Demarco, et al.
MMWR. Morbidity and Mortality Weekly Report|February 17, 2022
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022Jill M Ferdinands, Suchitra Rao, Brian E Dixon, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Open Forum Infectious Diseases|April 18, 2015
Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnelMaryrose R Laguio-Vila, Mark G Thompson, Sue Reynolds, et al.
Frontiers in Public Health|July 8, 2021
Logically Inferred Tuberculosis Transmission (LITT): A Data Integration Algorithm to Rank Potential Source CasesKathryn Winglee, Clinton J McDaniel, Lauren Linde, et al.
Pediatrics|September 2, 2021
Influenza Antiviral Treatment and Length of StayAngela P Campbell, Jerome I Tokars, Sue Reynolds, et al.
Vaccine|September 12, 2021
Influenza vaccine effectiveness within prospective cohorts of healthcare personnel in Israel and Peru 2016-2019Mark G Thompson, Giselle Soto, Alon Peretz, et al.
The Journal of Infectious Diseases|November 23, 2022
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022Malini B DeSilva, Patrick K Mitchell, Nicola P Klein, et al.
Vaccine|July 21, 2023
Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021Peter J Embi, Matthew E Levy, Palak Patel, et al.
The New England Journal of Medicine|September 8, 2021
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care SettingsMark G Thompson, Edward Stenehjem, Shaun Grannis, et al.
MMWR. Morbidity and Mortality Weekly Report|January 27, 2022
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022Mark G Thompson, Karthik Natarajan, Stephanie A Irving, et al.
MMWR. Morbidity and Mortality Weekly Report|March 3, 2022
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022Nicola P Klein, Melissa S Stockwell, Maria Demarco, et al.
MMWR. Morbidity and Mortality Weekly Report|February 17, 2022
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022Jill M Ferdinands, Suchitra Rao, Brian E Dixon, et al.
Pageof 4